These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3689364)

  • 41. A cyclic nucleotide-independent protein kinase in Leishmania donovani.
    Das S; Saha AK; Mukhopadhyay NK; Glew RH
    Biochem J; 1986 Dec; 240(3):641-9. PubMed ID: 3030283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C.
    Olivier M; Brownsey RW; Reiner NE
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7481-5. PubMed ID: 1323839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Leishmania donovani lipophosphoglycan (LPG) inhibits respiratory burst and chemotaxis of dog phagocytes.
    Panaro MA; Puccini V; Faliero SM; Marzio R; Marangi A; Lisi S; Brandonisio O
    New Microbiol; 1996 Apr; 19(2):107-12. PubMed ID: 8722306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leishmania donovani-induced ceramide as the key mediator of Akt dephosphorylation in murine macrophages: role of protein kinase Czeta and phosphatase.
    Dey R; Majumder N; Bhattacharjee S; Majumdar SB; Banerjee R; Ganguly S; Das P; Majumdar S
    Infect Immun; 2007 May; 75(5):2136-42. PubMed ID: 17220321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of electron and confocal microscopy in the study of Leishmania-macrophage interactions.
    Rasmusson B; Descoteaux A
    Microsc Microanal; 2004 Oct; 10(5):656-61. PubMed ID: 15525438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of a ricin-resistant mutant of Leishmania donovani that expresses lipophosphoglycan.
    Phillips MR; Turco SJ
    Glycobiology; 2015 Apr; 25(4):428-37. PubMed ID: 25472443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium.
    Rotenberg SA; Smiley S; Ueffing M; Krauss RS; Chen LB; Weinstein IB
    Cancer Res; 1990 Feb; 50(3):677-85. PubMed ID: 2297708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adrenocortical cytochrome P-450 responsible for cholesterol side chain cleavage (P-450scc) is phosphorylated by the calcium-activated, phospholipid-sensitive protein kinase (protein kinase C).
    Vilgrain I; Defaye G; Chambaz EM
    Biochem Biophys Res Commun; 1984 Dec; 125(2):554-61. PubMed ID: 6240267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purified rat brain calcium- and phospholipid-dependent protein kinase phosphorylates ribosomal protein S6.
    Le Peuch CJ; Ballester R; Rosen OM
    Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6858-62. PubMed ID: 6417656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B-50 protein kinase and kinase C in rat brain.
    Aloyo VJ; Zwiers H; Gispen WH
    Prog Brain Res; 1982; 56():303-15. PubMed ID: 6219430
    [No Abstract]   [Full Text] [Related]  

  • 51. Leishmania donovani activates nuclear transcription factor-kappaB in macrophages through reactive oxygen intermediates.
    Singh VK; Balaraman S; Tewary P; Madhubala R
    Biochem Biophys Res Commun; 2004 Sep; 322(3):1086-95. PubMed ID: 15336576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MDL 27,032 [4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone], an active site-directed inhibitor of protein kinase C and cyclic AMP-dependent protein kinase that relaxes vascular smooth muscle.
    Robinson PJ; Cheng HC; Black CK; Schmidt CJ; Kariya T; Jones WD; Dage RC
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1392-8. PubMed ID: 2175806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of a C-kinase inhibitory fraction.
    Holian O; Kumar R; Nyhus LM
    Biochem Int; 1986 Jun; 12(6):933-9. PubMed ID: 3741449
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
    Croft SL; Snowdon D; Yardley V
    J Antimicrob Chemother; 1996 Dec; 38(6):1041-7. PubMed ID: 9023651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan.
    Amprey JL; Im JS; Turco SJ; Murray HW; Illarionov PA; Besra GS; Porcelli SA; Späth GF
    J Exp Med; 2004 Oct; 200(7):895-904. PubMed ID: 15466622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of protein kinase C-alpha in the control of infection by intracellular pathogens in macrophages.
    St-Denis A; Caouras V; Gervais F; Descoteaux A
    J Immunol; 1999 Nov; 163(10):5505-11. PubMed ID: 10553077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spectrophotometric determination of functional characteristics of protein kinases with coupled enzymatic assay.
    Technikova-Dobrova Z; Sardanelli AM; Papa S
    FEBS Lett; 1991 Nov; 292(1-2):69-72. PubMed ID: 1959631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of protein kinase C by local anesthetics.
    Trudell JR; Costa AK; Hubbell WL
    Ann N Y Acad Sci; 1991; 625():743-6. PubMed ID: 2058922
    [No Abstract]   [Full Text] [Related]  

  • 60. Binding of protein kinase C to napthalenesulfonamide- and phenothiazine-agarose columns: evidence for direct interactions between protein kinase C and cationic amphiphilic inhibitors of the enzyme.
    O'Brian CA; Housey GM; Weinstein IB
    Biochem Pharmacol; 1987 Dec; 36(23):4179-81. PubMed ID: 3689446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.